,25 By virtue of its ability to coordinate multiple cellular processes, many of which impart aggressive traits to tumor cells, GIV has emerged as a bona-fide oncogene that supports cancer cell stemness, emergence of chemoresistance and invasion, favors aggressive tumor phenotypes in diverse types of cancers, and drives poor survival utcomes [reviewed in26]. Here, CCDC88A is linked to cancer.